Physician profile
Brian E Jaski
NPI 1194706242
$234,770.49
in general payments reported to CMS, 2019-2025
50 companies · $34K in 2025
The $34K reported for 2025 was more than what 89% of Advanced Heart Failure and Transplant Cardiology providers received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58K · 2020: $37K · 2021: $8,531 · 2022: $17K · 2023: $33K · 2024: $47K · 2025: $34K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $109K · Food and Beverage: $4,799 · Travel and Lodging: $435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $109,380.00 |
| Food and Beverage | $4,798.87 |
| Travel and Lodging | $435.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $203,579.61 | 2019-2025 | Clinical Trial Product, Lux-Dx Insertable Cardiac Monitor, Watchman Flx |
| Nuwellis, INC. | $11,130.03 | 2019-2023 | Aquadex Smartflow Console |
| Abbott Laboratories | $8,766.14 | 2019-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Aveir |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,765.74 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $1,375.13 | 2019-2025 | |
| Abiomed | $1,027.44 | 2019-2023 | Impella |
| Impedimed, INC. | $1,000.00 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $545.88 | 2019-2025 | Andexxa, Wainua, Farxiga |
| Pfizer INC. | $529.05 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $466.15 | 2022-2025 | Verquvo |
| Alnylam Pharmaceuticals INC. | $415.97 | 2019-2025 | Amvuttra |
| Medtronic, INC. | $358.52 | 2022-2025 | Onyx Frontier |
| Kiniksa Pharmaceuticals, Ltd. | $323.39 | 2021-2023 | Arcalyst |
| Cathworks, INC. | $286.35 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $244.31 | 2021-2022 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Jaski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.